Venrock Healthcare Capital Partners III, L.P. - Mar 31, 2025 SCHEDULE 13G/A Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (FDMT)

Filing Manager
Venrock Healthcare Capital Partners III, L.P.
Reporting Manager
Venrock Healthcare Capital Partners III, L.P.
Security
4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share
Symbol
FDMT
Shares outstanding
45.2M shares
Disclosed Ownership
678K shares
Ownership
1.5%
Form type
SCHEDULE 13G/A
Date filed
5/15/2025, 05:44 PM
Date of event
Mar 31, 2025
Previous filing
Feb 14, 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Venrock Healthcare Capital Partners III, L.P. 1.5% 678K 0 678K /s/ Sherman G. Souther By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC 1.5% 678K 0 678K /s/ Sherman G. Souther By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P. 1.5% 678K 0 678K /s/ Sherman G. Souther By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC 1.5% 678K 0 678K /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC 1.5% 678K 0 678K /s/ Sherman G. Souther By Sherman G. Souther, Authorized Signatory
Nimish Shah 1.5% 678K 0 678K /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact
Bong Y Koh 1.5% 678K 0 678K /s/ Sherman G. Souther By Sherman G. Souther, Attorney-in-fact